Paul Calabresi

Q: What Schools Are Affiliated With Paul Calabresi

Paul Calabresi is affiliated with the following schools: Brown University, Yale University

Paul Calabresi's AcademicInfluence.com Rankings

Paul Calabresi

Philosophy

#7148

World Rank

#10319

Historical Rank

Logic

#4218

World Rank

#5483

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Paul Calabresi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul Calabresi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Chemotherapy of neoplastic diseases. (1962) (403)
Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. (1978) (325)
N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. (1979) (269)
Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with Camptothecin* (2002) (261)
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? (1998) (261)
Psoriasis and occlusive vascular disease (1978) (205)
Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. (1993) (180)
A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. (1997) (174)
Porto-caval and porto-pulmonary anastomoses in Laennec's cirrhosis and in heart failure. (1957) (166)
Heterogeneity of cancer cells from a single human colon carcinoma. (1981) (164)
Human microvascular endothelial cells express receptors for platelet-derived growth factor. (1991) (160)
Tumor angiogenesis as a prognostic factor in cervical carcinoma. (1995) (152)
Immunosuppressive effects of cytosine arabinoside and methotrexate in man. (1969) (133)
Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man. (1966) (133)
Clinical and pharmacological implications of cancer cell differentiation and heterogeneity. (1979) (131)
Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. (1966) (121)
Identification of the enzymatic pathways of nucleotide metabolism in human lymphocytes and leukemia cells. (1973) (116)
Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. (1982) (113)
Initial clinical studies with 5-iodo-2'-deoxyuridine. (1961) (109)
Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. (1995) (105)
Fluorescent antiglobulin studies in leukopenic and related disorders. (1959) (104)
Cell‐mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma (1973) (96)
Actions of TNF and INF-γ on Angiogenesis In Vitro (1990) (81)
Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells. (1975) (78)
Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine. (1984) (76)
Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent. (2001) (69)
Nucleotide profiles of the formed elements of human blood determined by high-pressure liquid chromatography. (1973) (69)
Preoperative pulmonary function testing (1990) (69)
5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. (1990) (68)
Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. (1992) (66)
Treatment of advanced Wegener's granulomatosis with azathioprine and duazomycin A. (1968) (65)
Clinical and pharmacological studies with 2',3',5'-triacetyl-6-azauridine. (1963) (62)
In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse (1992) (60)
Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice. (1982) (59)
Summary of current information on 6-azauridine. (1962) (59)
Inhibition of the growth of human colon cancer xenografts by polar solvents. (1982) (57)
The Granulocyte Response to an Endotoxin (Pyrexal) as a Measure of Functional Marrow Reserve in Cancer Chemotherapy (1962) (54)
CURRENT STATUS OF CLINICAL INVESTIGATIONS WITH 6-AZAURIDINE, 5-IODO-2'-DEOXYURIDINE, AND RELATED DERIVATIVES. (1963) (54)
DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS. (1961) (53)
Intraneoplastic diversity. (1982) (52)
Polycythemia vera. I. Clinical and laboratory manifestations. (1959) (52)
Alteration of the survival response of two human colon carcinoma subpopulations to x-irradiation by N,N-dimethylformamide. (1982) (52)
Chemotherapy of cell‐line‐derived human colon carcinomas in mice immunosuppressed with antithymocyte serum (1977) (50)
The “induction” of leukocyte and erythrocyte dihydrofolate reductase by methotrexate (1965) (48)
Cardiac rehabilitation services (1988) (48)
Medical Oncology: Basic Principles and Clinical Management of Cancer (1993) (47)
Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages. (1994) (45)
Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity. (1990) (45)
Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors. (1972) (43)
Selective suppression of humoral immunity by antineoplastic drugs. (1976) (43)
Alterations in human pyrimidine metabolism as a result of therapy with 6-azauridine. (1961) (43)
Actions of TNF and IFN-gamma on angiogenesis in vitro. (1990) (42)
Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety. (1980) (42)
Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo. (1992) (42)
Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma. (1990) (41)
RADIATION AND 5-FLUOROURACIL: A CONTROLLED CLINICAL STUDY. (1963) (40)
N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cells. (1981) (40)
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor. (1998) (39)
Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting. (2003) (39)
Selective suppression of humoral and cellular immunity with cytosine arabinoside. (1972) (38)
A phase I trial of continuous infusion cisplatin (1987) (38)
Detection of chemical mutagens using a host-mediated assay (L5178Y) mutagenesis system. (1974) (37)
Suppression of Infections Resulting from a Deoxyribonucleic Acid Virus (Vaccinia) By Systemic Administration of 5-Iodo-2′-Deoxyuridine (1963) (37)
Modulation of bleomycin‐induced pulmonary toxicity in the hamster by the antioxidant amifostine (1998) (37)
The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma (2004) (35)
Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer (2004) (34)
A prototype for a hybrid artificial liver. (1978) (33)
Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice. (1977) (33)
Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumors. (1981) (32)
Drug therapy. Immunosuppressive agents. I. (1973) (31)
Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice (2004) (31)
Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine. (1963) (30)
A synopsis of recent investigations of 6-azauridine (NSC-32074). (1960) (30)
A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue. (1979) (30)
Thermal survival characteristics of cell subpopulations isolated from a heterogeneous human colon tumor. (1983) (29)
Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4. (1990) (28)
Drug therapy: immunosuppressive agents (second of two parts). (1973) (27)
CLINICAL STUDIES WITH SYSTEMIC ADMINISTRATION OF ANTIMETABOLITES OF PYRIMIDINE NUCLEOSIDES IN VIRAL INFECTIONS * (1965) (27)
The effect of Taurolidine on adherent and floating subpopulations of melanoma cells (2003) (27)
Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. (1993) (27)
Diagnostic evaluation of the carotid arteries (1988) (26)
The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism. (2002) (26)
Selective modification of the X ray survival response of two mouse mammary adenocarcinoma sublines by N,N-dimethylformamide. (1981) (25)
Ultrastructure of myeloma cells in a case with crystalcryoglobulinemia (1977) (25)
Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse. (1974) (24)
Detection of elevated basic fibroblast growth factor during early hours of in vitro angiogenesis using a fast ELISA immunoassay. (1994) (24)
Training program in medical oncology. (1973) (23)
Evaluation of patients after recent acute myocardial infarction. American College of Physicians. (1989) (23)
OBSERVATIONS ON OLFACTORY INTENSITY. I. TRAINING PROCEDURE, METHODS, AND DATA FOR TWO ALIPHATIC HOMOLOGOUS SERIES (1954) (23)
Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line. (2000) (23)
Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I study. (1990) (21)
Human IgG cryoglobulin with tubular crystal structure. (1973) (21)
Amifostine modulation of bleomycin-induced lung injury in rodents. (1999) (21)
Inhibition by 5-Iododeoxyuridine of the Oncogenic Effects of Adenovirus Type 12 in Hamsters (1963) (21)
Quantification and pharmacological dissection of oxazolone-induced contact sensitivity in the mouse. (1974) (20)
Alteration of antibody synthesis in the rat by cytosine arabinoside. (1969) (20)
Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice (1990) (20)
Selective alteration of immunocompetence with methotrexate and 5-fluorouracil. (1974) (20)
Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging (2002) (20)
Polycythemia vera. II. Course and therapy. (1959) (20)
Regional protection in cancer chemotherapy. 1. Infusions of thymidine into external carotid artery of patients receiving systemic 5-iodo-2'-deoxyuruidine. (1962) (20)
Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse. (1983) (18)
Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy (1992) (18)
Metastasis of a human pancreatic adenocarcinoma (RWP-1) in nude mice. (1982) (18)
Detection of carcinoembryonic antigen in the media of cultures of carcinomatous cells of digestive-system origin. (1972) (17)
Response of a human colon adenocarcinoma (DLD-1) to X irradiation and mitomycin C in vivo. (1983) (16)
Investigations with 5‐azaorotic acid, an inhibitor of the biosynthesis of pyrimidines de novo (1965) (16)
Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine. (1991) (15)
Alteration of immunocompetence by mammary tumor virus. (1973) (15)
Increased activity of alkaline phosphatase in leukemic cells from patients resistant to thiopurines. (1979) (15)
Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice. (1983) (15)
"COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude mice. (1983) (14)
Myeloproliferative syndrome with leukemia preceding polycythemia vera; a case report. (1958) (14)
5-Iodo-2'-deoxyuridine (IUDR; NSC-39661) given intraventricularly in the treatment of progressive multifocal leukoencephalopathy. (1973) (14)
Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma. (1987) (14)
Cancer: crab or chimera? The clinical implications of cancer cell heterogeneity. (1981) (14)
Cell culture of the mucinous variant of human colorectal carcinoma. (1988) (14)
Basic principles and clinical management of cancer (1988) (13)
How to study the gallbladder (1988) (12)
Cytological screening for uterine cancer through physicians' offices; report of 65,163 women examined over a period of ten years (1947-1956). (1958) (12)
Cancer at a crossroads : a report to Congress for the nation (1995) (11)
Regional protection in cancer chemotherapy. II. Preliminary studies with hypogastric artery infusion of thymidine during treatment with 5-iodo-2'-deoxyuridine. (1962) (11)
Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative. (1997) (11)
Demonstration of L. E. cells at local inflammatory sites in patients with systemic lupus erythematosus. (1960) (11)
Pharmacological and clinical studies with triacetyl 6-azauridine. (1962) (11)
Differential characteristics of two newly established human breast carcinoma cell lines. (1985) (10)
Selective immunosuppression by drugs in balanced immune responses. (1974) (10)
Receptors for platelet-derived growth factor on microvascular endothelial cells. (1992) (10)
Recombinant interferon α2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system (1999) (10)
Indications for carotid endarterectomy (1989) (10)
Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2'-deoxycoformycin (pentostatin). (1982) (10)
Gene-modified cells for the treatment of cancer. (1995) (9)
Gene-modified cells for the treatment of cancer. (1995) (9)
Leukemia after cytotoxic chemotherapy--a pyrrhic victory? (1983) (9)
Successful therapy of crystalcryoglobulinemia: a case report. (1979) (9)
Continuous intravenous infusions of 5‐fluoro‐2′‐deoxyuridine in the treatment of solid tumors (1973) (9)
Monoclonal antibody production in artificial capillary cultures. Abstr. (1981) (8)
Enhanced Suppression of the Secondary Immune Response by Combination of 6-Mercaptopurine ‘Duazomycin A’ (1963) (8)
Concerns of special populations (1997) (8)
Clinical, pharmacologic, and immunologic effects of 2'‐deoxycoformycin (1988) (8)
The metabolism of uracil‐2‐14C and the granulocyte response to endotoxin as indicators of the toxicity produced in patients receiving 5‐fluorouracil (1967) (8)
Hemodynamic effects of potentially useful antineoplastic agents. (1983) (8)
Tumor-associated antigens produced by mouse mammary tumor cells in artificial capillary culture. (1982) (7)
Clinical and pharmacologic effects of combinations of 6-thioguanine and duazomycin A in patients with neoplastic disease. (1965) (7)
Nude mouse model of the melanosis syndrome. (1983) (7)
NUCLEOSIDE ANALOGS IN THE TREATMENT OF NONNEOPLASTIC DISEASES * (1975) (7)
Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents. (1972) (7)
Tumor immunity in melanoma patients as assessed by colony inhibition and microcytotoxicity methods: a preliminary report. (1973) (7)
Survival responses of cell subpopulations isolated from a heterogeneous human colon tumour after combinations of hyperthermia and X-irradiation. (1983) (7)
Cancer Cell Differentiation (1982) (6)
Protection against hyperthermic cell killing of mouse mammary adenocarcinoma cells in vitro by N,N-dimethylformamide. (1981) (6)
RECENT STUDIES WITH 5-IODODEOXYURIDINE (IUDR) AND RELATED COMPOUNDS. (1963) (6)
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology. (1985) (6)
A role for MAP kinase in the antitumor activity of a nucleoside analog (2002) (6)
Benzylacyclouridine Enhances 5-Fluorouracil Cytotoxicity against Human Prostate Cancer Cell Lines (1998) (6)
Stimulation of hemolysin plaque-forming cells by idoxuridine. (1975) (6)
Simplified estimation of mouse isohemagglutinins by microassay. (1969) (6)
The use of 5-iodo-2'-deoxyuridine (IUDR) in Orabase and plastibase for treatment of oral herpes simplex. (1969) (5)
Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test. (1973) (5)
Microanalysis For Platinum and Magnesium in Body Fluids and Brain Tissue of Mice Treated with Cis-Platinum Using Graphite Filament Plasma Emission Spectroscopy (1986) (5)
Clinical experiences with 5-fluorouracil. (1960) (5)
Principles of current cancer chemotherapy. (1983) (5)
Responses of oxic and hypoxic human colon tumor cells to hyperthermia. (1982) (5)
Enhanced Suppression of Experimental Allergic Encephalomyelitis by Combination Chemotherapy with Duazomycin-A and 6-Mercaptopurine∗ (1969) (5)
Predictive Sensitivity of Human Cancer Cells in vivo Using Semipermeable Polysulfone Fibers (1998) (5)
Medical alternatives to alternative medicine (1999) (5)
Immunosuppressive Effects of Selected Metabolic Inhibitors in Vivo and in Vitro ∗ (1968) (5)
Synthesis and biological evaluation of certain 4‐alkylamino and 4‐arylalkylamino derivatives of the imidazo[4,5‐d]pyridazine and v‐triazolo[4,5‐d]pyridazine ring systems (1982) (4)
CELLULAR AND BIOCHEMICAL ASPECTS OF HUMAN TUMOR CELL GROWTH AND FUNCTION IN HOLLOW FIBER CULTURE (1985) (4)
Modification of the response of mouse skin to x-irradiation by a polar solvent, N,N-dimethylformamide. (1982) (4)
A Phase I‐II Trial of Continuous‐Infusion Cisplatin, Continuous‐Infusion 5‐Fluorouracil, and VP‐16 in Colorectal Carcinoma (1990) (4)
Immunologic Tolerance in Rats to Type Specific Antigens of Human Erythrocytes.∗ † (1958) (4)
Training programs in medical oncology. (1986) (4)
Clinical trial of weekly pyrazofurin. (1979) (4)
Evaluation of cell-mediated reactivity and serum blocking factors in melanoma patients on chemotherapy. (1975) (4)
Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil (2004) (3)
Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin). (1983) (3)
Radiosensitivity of human colon carcinoma cells in vitro and in vivo. Abstr. (1980) (3)
Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil. (1982) (3)
Characterization of two newly established human pancreatic cancer cell lines grown in monolayer and artificial capillary cultures and in nude mice. Abstr. (1981) (3)
Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors. (1979) (3)
A therapeutic monitoring assay for N-methylformamide in human serum and urine. (1983) (3)
Effect of 6-azauridine on plasma cell tumors of mice: correlation of antitumor effect with inhibition of orotic acid metabolism. (1967) (3)
Heterogeneity of mmtv antigen expression and induction in mouse mammary tumor cells. Abstr. (1979) (2)
Modulation of fudr host toxicity by two benzylacylouridine analogs (1987) (2)
Tissue analysis of N-methylformamide: organ distribution. (1984) (2)
Studies on the Role of the Lymphocyte in the Immune Response † (1964) (2)
Geriatric clinical pharmacologist and medical oncologist: A new partnership? (1997) (2)
39th Annual European Brain and Behaviour Society Abstracts (2007) (2)
Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil (1988) (2)
Selective immunosuppression with methotrexate and 5-fluorouracil. Abstr. (1973) (2)
Stimulatory effects of 5-lodo-2'-deoxyuridine on number and function of splenic B- and T-cells and of macrophages in C3HeB/FeJ mice. (1976) (2)
Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice. (1990) (2)
Use of allopurinol for control of hyperuricemia in leukemia and lymphoma. (1967) (2)
Selective manipulation of immunological responses with with cytosine arabinoside. Abstr. (1970) (2)
Induction of doxorubicin resistance in heterogeneous human colon tumor cells by N-methylformamide. (1986) (2)
Studies on the kinetics of marrow regeneration after local irradiation of the femur in rabbits. (1968) (1)
Book ReviewMedical Care, Medical Costs: The search for a health insurance policy (1987) (1)
2'-Deoxycoformycin-induced hemolysis in the mouse. (1982) (1)
Growth inhibition by polar solvents of human colon cancer xenografts in nude mice. Abstr. (1982) (1)
Effect of leucovorin on selective immunosuppression with methotrexate (mtx) and 5-fluorouracil (5-fu) in c3heb/fej mice. Abstr. (1975) (1)
Artificial capillary culture studies of human tumor cell growth, differentiation, and marker production. (1987) (1)
Mono clonal antibody production in artificial capillary cultures (1981) (1)
Establishment and Characterization of Two Human Pancreatic Cancer Cell Lines Tumorigenic in Athymic Mice 1 (2006) (1)
5’-methylthioadenosine phosphorylase as a chemotherapeutic target enzyme (1982) (1)
Combination Drug Therapy (2005) (1)
Human leukocyte reactivity to penicilloylated erythrocytes. (1974) (1)
Legislative support for access to state-of-the-art cancer treatment in Rhode Island. (1998) (1)
The value of the fluorescent antiglobin technic in the differential diagnosis of aleukemic leukemia. (1962) (0)
SYNTHESIS AND BIOLOGICAL EVALUATION OF CERTAIN 4‐ALKYLAMINO AND 4‐ARYLALKYLAMINO DERIVATIVES OF THE IMIDAZO(4,5‐D)PYRIDAZINE AND V‐TRIAZOLO(4,5‐D)PYRIDAZINE RING SYSTEMS (1982) (0)
Effects of la,25-Dihydroxyvitamin D3 on the Human Chronic Myelogenous Leukemia Cell Line RWLeu-41 (2006) (0)
Establishment and Characterization of Two Human Pancreatic Cancer Cell Lines Tumorigenic in Athymic Mice1 (2006) (0)
Results of the National Cancer Advisory Board Evaluation of the National Cancer Program (1996) (0)
391 – IDIFFERENCES IN SUSCEPTIBILITY TO ANTI-NEOPLASTIC DRUGS AMONG SUBPOPULATIONS OF TUMOR CELLS OBTAINED FROM A SINGLE TUMOR (1978) (0)
Selective alteration of immunological competence by mammary tumor virus. Abstr. (1971) (0)
Quantitative studies of cellular and humoral immune responses to tumor cells after treatment with antineoplastic agents. Abstr. (1969) (0)
Multiple effects of 5-flourouracil (5-fu) on immunocompetence. Abstr. (1972) (0)
N,n-dimethylformanide (dmf) induces premature senescence of murine bone marrow cell cultures. Abstr. (1983) (0)
Medicinske alternative alternativni medicini (2000) (0)
Report on the Discussion of the Fourth Session (1973) (0)
Growth of heterologous marrow in difh@@@fusion chambers implan in athymic, "nude" mice. Abstr. (1977) (0)
CEREBROSPINAL FLUID VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH BRAIN TUMORS (1997) (0)
The Rhode Island Cancer Council. (2002) (0)
Taurolidine or taurultamo for use in treating prostate, colon, lung and for the treatment of recurrent glioblastoma multiforme (2000) (0)
Synergism of immunosuppressive agents. Abstr. (1973) (0)
Clinical and Pharmacological Studies of Methotrexate-Minimal Leucovorin Rescue plus Fluorouracil 1 (2006) (0)
Book ReviewPulmonary Metastasis (1979) (0)
Changes in the in vivo patterns and subsequent metastasis development of indium-111 radiolabeled b16 melanoma cells after growth in dimethylformamide (dmf). Abstr. (1982) (0)
Discussion (1972) (0)
Community cancer control task forces in Rhode Island. (2004) (0)
Triacetyl 6-Azauridine in Mycosis Fungoides (1968) (0)
Gastric pepsin secretion and ABO blood groups in polycythemia vera (1959) (0)
Book ReviewIn Search of Equity: Health needs and the health care system (1983) (0)
A human pancreatic adenocarcinoma (rwp 1) which metastasizes in athymic mice. Abstr. (1982) (0)
Myelogenous Leukemia Cell Line RWLeu-4 on the Human Chronic 3 , 25-Dihydroxyvitamin D α Effects of 1 Updated (2006) (0)
Activation of the fibroblast growth factor receptor associated tyrosine kinase in normal human fibroblasts (1989) (0)
In vitro hyperthermic sensitivities of a heterogeneous human colon adenocar cinoma (1980) (0)
Inhibition by puromycin in vitro of cell-bound immunity induced by tumor homografts. Abstr. (1967) (0)
Use of taurolidine or taurultamo for the manufacture of a medicament for the treatment of tumors (2000) (0)
Incorporation of iododeoxyuridine into neoplastic DNA: A fraudulent magic bullet? (1990) (0)
Medicine in the year 2000: a symposium. (1978) (0)
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology. (1985) (0)
/ V , / V-Dimethylformamide and Sodium Butyrate Modulation of the Activities of Purine-metabolizing Enzymes in Cultured Human Colon Carcinoma Cells 1 (2006) (0)
458 – ANALYSIS OF ADVERSE DRUG REACTIONS IN HOSPITALIZED PATIENTS (1977) (0)
Book ReviewRural Health Care (1983) (0)
A Clinical and PharmacologicalStudy of High-Dose Methotrexate with Minimal Leucovorin Rescue1 (2006) (0)
Potentially curable neoplasms. (1986) (0)
The effect of thymidine (tdr) upon combination chemotherapy with 5-fluoro-2'-deoxyuridine (f) and 5-iodo-2'-deoxyuridine (i). Abstr. (1978) (0)
Sensitivity of l5178y cells in culture to antileukemic agents after treatment with l-asparaginase and l-asparagine rescue. Abstr. (1970) (0)
Cancer in the new millennium. (2002) (0)
DETERMINANTS OF MATERNAL AND INFANTICIDAL BEHAVIOR IN FEMALE MOUSE F1 HYBRIDS (2007) (0)
Subject Index, Vol. 55, 1997 (1997) (0)
Melanosis in nude mice bearing a human melanoma xenograft. Abstr. (1981) (0)
Book ReviewBoston at Risk: A report from The Boston Foundation Primary Health Care Seminar (1986) (0)
Synergism of Methotrexate with 1 muran and with 5-Fluorouracil and Their Effects on Hemolysin Plaque-forming Cell Production in the Mouse 1 (2006) (0)
Synergism of Methotrexate with 1muran and with 5-Fluorouracil and Their Effects on Hemolysin Plaque-forming Cell Production in the Mouse1 (2006) (0)
Contents, Vol. 55, 1997 (1997) (0)
From the chairman (0)
Future horizons in clinical pharmacology. (1968) (0)
ABLE 2 EXCRETION PRODUCTS IN URINE AFTER AZUR THERAPY Diagnosis Acute monocytie leukemia Chronic granulocytic leukemia Acute granuloeytic leukemia Acute granuloeytie leukemia Hodgkin ' s disease Patient (2007) (0)
Advances in Brief Antitumor Activity of Basic Fibroblast Growth Factor-Saporin Mitotoxin in Vitro and in Vivo ' (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paul Calabresi?

Paul Calabresi is affiliated with the following schools:

Paul Calabresi's Academic­Influence.com Rankings

Why Is Paul Calabresi Influential?

Paul Calabresi's Published Works

Published Works

What Schools Are Affiliated With Paul Calabresi?

Paul Calabresi's AcademicInfluence.com Rankings